MDEpiNet

@MDEpiNet_ppp

Building a national evaluation system by improving and integrating infrastructure for real-world data, developing methodologies, and research.

USA
Vrijeme pridruživanja: prosinac 2014.

Tweetovi

Blokirali ste korisnika/cu @MDEpiNet_ppp

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MDEpiNet_ppp

  1. proslijedio/la je Tweet
    31. sij
    Poništi
  2. proslijedio/la je Tweet
    1. velj

    Transapical mitral valve replacement using ⁦⁦ in the real world. Hoping post approval ‘registry’ in Europe will become true surveillance registry to ensure long-term safety ⁦⁩ ⁦

    Poništi
  3. proslijedio/la je Tweet
    28. sij

    Proud of being part of this rising new journal on innovative research in surgery! further pushes the quality improvement initiative in PAOD treatment together with Read the study protocol open access!

    Poništi
  4. proslijedio/la je Tweet
    30. sij

    Mentoring academy townhall by Dean and consistent and strong message to be honest with mentees! Mentoring is a challenge in modern academic medicine with few incentives- comes from the heart

    Poništi
  5. proslijedio/la je Tweet

    is led by and Dr. McCulloch serves as Professor at the and the Chair of the while Dr. Sedrakyan is a Professor and the leader

    Poništi
  6. proslijedio/la je Tweet

    We have an all star cast of amazing editors from many interventional surgical fields and from across the globe. to name a few!

    Poništi
  7. proslijedio/la je Tweet
    21. sij
    Poništi
  8. proslijedio/la je Tweet
    9. sij

    37,914 patients treated between 2010-2018 were included in this very robust propensity score matched analysis of longitudinal population-based health insurance claims to determine long-term survival and relevant outcomes after paclitaxel-coated devices!

    , , i još njih 4
    Prikaži ovu nit
    Poništi
  9. proslijedio/la je Tweet
    9. sij

    This is the long-term elluting study that regulators needed very powerful study using European data

    Poništi
  10. proslijedio/la je Tweet
    20. pro 2019.
    Poništi
  11. proslijedio/la je Tweet
    11. pro 2019.
    Poništi
  12. proslijedio/la je Tweet
    12. pro 2019.

    Thank you . Many keypersons were learning about , , and important of international collaborations.

    Poništi
  13. proslijedio/la je Tweet
    11. pro 2019.

    Another day of discussions at successful launch of in Japan. Fantastic talks by and over 200 Various registry leaders in Japan participating in the meeting

    Poništi
  14. proslijedio/la je Tweet
    10. pro 2019.

    Excellent opportunities for real world evidence in Japan. working with , and the leadership of NCGM to launch MDEPINet-Japan

    Poništi
  15. proslijedio/la je Tweet
    3. pro 2019.
    Odgovor korisnicima i sljedećem broju korisnika:

    Excellent article concerning regional differences in abdominal aortic aneurysm repair in Germany! Congratulations to the team of for publishing this real-world evidence study in VASA!

    Poništi
  16. proslijedio/la je Tweet
    5. pro 2019.

    Very interesting upcoming project of concerning arch pathologies with aberrant right subclavian artery

    Poništi
  17. proslijedio/la je Tweet
    21. stu 2019.

    clearly affects our major international collaborations but we have some solutions using distributed research approaches

    Poništi
  18. proslijedio/la je Tweet
    19. stu 2019.

    Congratulations to for study funding approval. Find study info here.

    Poništi
  19. proslijedio/la je Tweet
    19. stu 2019.

    Fantastic success for SPARED and technology assessments for devices! thank you for leadership! Important for sustainability approach

    Poništi
  20. proslijedio/la je Tweet
    19. stu 2019.

    At ICVR meeting Sal Scali from presenting advanced Volume threshold analysis for AAA at no center level V-O relationship for . Huge implications for practice and regulation

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·